There is no panel matching the key "Alert"
There is no panel matching the key "MicroAlert"

Give Us a Call: (608) 782-7300

Wesley D. Fox

Wesley D. Fox, MD

Specialties: Resident and Family Medicine
No Patient Experience Reviews – Why Not?

Gundersen Health System requires a minimum of 30 completed patient surveys in a 12-month period for each clinician before posting a clinician’s rating. Industry best practice is clear that more data provides a more accurate picture of the patient experience.

Main Location

  • La Crosse Campus

    1900 South Avenue La Crosse, WI 54601

    • Office Phone: (608) 775-0375
    • Fax: (608) 775-6198

Profile

Personal Interests

Wesley "Wes" Fox grew up in Arpin, Wisconsin, with three siblings and his dog, Miley. With a mom as a teacher and a dad in the paper industry, Wes is the first person in his family to work in the medical field. He graduated with a Bachelor's degree from the University of Wisconsin-Madison majoring in Biological Aspects of Conservation with a minor in Business. He went on to earn a medical degree with distinction in public health from the University of Wisconsin School of Medicine and Public Health. In addition to comprehensive family medicine, his medical interests include sports medicine and environmental health. In his free time, you can find Wes up in his tree stand, in his canoe, or checking a National Park off his bucket list.

Published Works

  • Fox WD. Long-term micronutrient surveillance after bariatric surgery. 2018
  • Waller CJ, Cogbill TH, Kallies KJ, et al. Contemporary management of subclavian and axillary artery injuries - a Western Trauma Association multicenter review. 2017
  • Waller CJ, Cogbill TH, Kallies KJ, et al. Contemporary management of subclavian and axillary artery injuries-A Western Trauma Association multicenter review. J Trauma Acute Care Surg. 2017;83(6):1023-1031. doi: 10.1097/TA.0000000000001645 [doi]
  • Deng L, Xu-Monette ZY, Loghavi S, et al. Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium. Leukemia. 2016;30(2):361-372. doi: 10.1038/leu.2015.237 [doi]
  • Dorsey ER, Wagner JD, Bull MT, et al. Feasibility of Virtual Research Visits in Fox Trial Finder. J Parkinsons Dis. 2015;5(3):505-515. doi: 10.3233/JPD-150549 [doi]
  • Li L, Xu-Monette ZY, Ok CY, et al. Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma. Oncotarget. 2015;6(27):23157-23180. doi: 4319 [pii]
  • Visco C, Li Y, Xu-Monette ZY, et al. Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. Leukemia. 2012;26(9):2103-2113. doi: 10.1038/leu.2012.83; 10.1038/leu.2012.83
  • Lubner SJ, Loconte NK, Holen KD, et al. A phase II study of oxaliplatin, 5-fluorouracil, leucovorin, and high-dose capecitabine in patients with metastatic colorectal cancer. Clin Colorectal Cancer. 2010;9(3):157-161. doi: 10.3816/CCC.2010.n.021
  • Malik JT, Chih JL, Moller MB, et al. Validation and application of new immunostain alogorithm for molecular subtype classification in diffuse large B-cell lymphoma (DLBCL): An International DLBCL Rituxan-CHOP Consortium Program Study. 2010:Abstract 1902
  • Descipio C, Schneider L, Young TL, et al. Subtelomeric deletions of chromosome 6p: molecular and cytogenetic characterization of three new cases with phenotypic overlap with Ritscher-Schinzel (3C) syndrome. Am J Med Genet A. 2005;134(1):3-11. doi: 10.1002/ajmg.a.30573 [doi]
Take Action
Love + Medicine

Every day, Gundersen Health System staff deliver great medicine plus a little something extra—we call it Love + Medicine.

Share Your Story